RxSaveCard on Relentless Health Value: Solving the GLP-1 Cost Dilemma
Plan sponsors face an impossible choice with GLP-1 medications: control volume or control unit cost – but not both. This fundamental tradeoff is reshaping how employers approach weight loss medication
RxSaveCard Partners with Scripta Insights for Precision Prescription Outreach
New integration with Scripta Insights enables targeted, medication-specific member engagement based on real prescription data.
LillyDirect Expands Zepbound Access with New High-Dose Options at $499
LillyDirect adds 12.5mg and 15mg vials to their Zepbound self-pay lineup, available for shipment starting August 1, 2025.
Learn About the RxSaveCard in Under 3 Minutes: Watch The 3x3x3 Challenge Now
Check out this insightful interview with our CEO, Chris Crawford, featured on the BenefitsAlly 3x3x3 Challenge! The 3x3x3 Challenge is a quick and informative video format where industry partners answer
Access Affordable Zepbound Through RxSaveCard: Lilly Offers New Low-Cost Option
Employers seeking to offer their employees access to weight-loss medications like Zepbound often face a significant barrier: high costs associated with traditional pharmacy benefit manager (PBM) pricing. The Rx Save
Expand Your Pharmacy Benefit Options: Access Mark Cuban’s Cost Plus Drug Company with RxSaveCard
Frustrated by your PBM’s restrictions on accessing low-cost medications from Mark Cuban Cost Plus Drug Company? The Rx Save Card offers a solution that empowers employers and employees to take